Comparison of UVA1 Phototherapy Versus Photochemotherapy for Patients With Severe Generalized Atopic Dermatitis

• Status: Completed
• Trial end date: 2009-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare the efficacy, tolerability and remission duration of UVA 1 therapy versus 5-MOP UVA photochemotherapy for patients with severe generalized atopic dermatitis.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Medical University of Vienna
• Treatments: 5-Methoxypsoralen; Emollients; Methoxsalen

Criteria

Inclusion Criteria:

• Patients with severe generalized atopic dermatitis (SCORAD Score > 45)

• Patients older than 18 years

Exclusion Criteria:

• SCORAD Score < 45

• Pregnant and lactating women

• Patients with severe general diseases

• Abnormal UVA sensitivity

• Intake of photosensitizing drugs

• Local corticosteroid treatment < 2 weeks before entering the study

• Photo(chemo)therapy or systemic treatment for atopic dermatitis < 4 weeks before the study